Rani Bansal, MD
Assistant Professor of Medicine, Duke University School of Medicine; Member, Duke Cancer Institute
Highlights
- Medical oncologist specializing in breast cancer care and research
- Principal investigator on multiple phase III clinical trials, including studies of novel antibody-drug conjugates, endocrine therapies, and targeted agents
- Research focus on expanding access to clinical trials for diverse patient populations
Rani Bansal, MD is an assistant professor of medicine at Duke University School of Medicine and a member of the Duke Cancer Institute. A medical oncologist, Dr. Bansal specializes in the care of people with breast cancer, with a particular focus on advancing clinical trial development and expanding access to innovative treatments across diverse patient populations.
Dr. Bansal has published extensively in leading medical journals, contributing more than two dozen articles on breast cancer biology and treatment. Her research focuses on developing new therapies for breast cancer, including HER2-positive and estrogen receptor-positive disease. As principal investigator on several large phase III clinical trials, she is leading studies that test new therapies and treatment combinations for breast cancer.
In addition to her clinical and research responsibilities, Dr. Bansal is committed to ensuring equitable access to clinical trials for diverse patient populations.
